Welcome to Scribd, the world's digital library. Read, publish, and share books and documents. See more
Download
Standard view
Full view
of .
Look up keyword
Like this
1Activity
0 of .
Results for:
No results containing your search query
P. 1
The Victoza - Pancreatitis Issue: Some Related Developments From April 2011 To April 2012

The Victoza - Pancreatitis Issue: Some Related Developments From April 2011 To April 2012

Ratings: (0)|Views: 8 |Likes:
Published by Thomas J. Lamb
The Victoza - Pancreatitis Issue: Some Related Developments From April 2011 To April 2012

A Drug Safety Controversy Continues: Whether It Is The Diabetes Drug Or The Diabetes Which Causes Pancreas Disease

http://www.drug-injury.com/druginjurycom/2012/05/victoza-pancreatitis-side-effect-diabetes-drug-safety-issue-developments-time-line.html
The Victoza - Pancreatitis Issue: Some Related Developments From April 2011 To April 2012

A Drug Safety Controversy Continues: Whether It Is The Diabetes Drug Or The Diabetes Which Causes Pancreas Disease

http://www.drug-injury.com/druginjurycom/2012/05/victoza-pancreatitis-side-effect-diabetes-drug-safety-issue-developments-time-line.html

More info:

Categories:Types, Research, Law
Published by: Thomas J. Lamb on May 08, 2012
Copyright:Attribution Non-commercial

Availability:

Read on Scribd mobile: iPhone, iPad and Android.
download as PDF, TXT or read online from Scribd
See more
See less

05/08/2012

pdf

text

original

 
A Drug Safety Controversy Continues: Whether It Is The Diabetes Drug OrThe Diabetes Which Causes Pancreas Disease
 
(Posted by Tom Lamb atwww.DrugInjuryWatch.comon May 4, 2012; seehttp://bit.ly/IQQEB9 
 
)
As regards the possible association between Victoza and pancreatitis as a side effect of this diabetes drugfrom Novo Nordisk, there have quite a few assorted developments during the period April 2011 to April2012. In order to get those all out in front of us, and so as to see how this drug safety issue emerged andwhere it may be headed going forward, we offer the following time-line of sorts.
April 2010
The Annals of Pharmacotherapy 
."Medical Journal Withdraws Article About Januvia And Byetta After It Gets Letters From Two DrugCompanies", Drug Injury Watch.According to a news item published April 11, 2011 by
The British Medical Journal 
(
BMJ 
),letters written by Merck and Novo Nordisk to Anil Rustgi, the editor-in-chief of
Gastroenterology 
, resulted in that journal withdrawing an article which it had posted on itswebsite about how Januvia (sitagliptin) and Byetta (exenatide) have been associated withan increased risk of pancreatitis as well as several cancers.From this April 2011
BMJ 
P.S.
The diabetes drug Januvia is marketed by Merck.Byetta is marketed by Amylin Pharmaceuticals and Eli Lilly.Novo Nordisk has a relatively new diabetes drug, Victoza (approved by FDA in 2010),which is in the same class of drugs as Byetta. Victoza (liraglutide) has been linked topancreatitis, also.
June 2011
Medscape 

You're Reading a Free Preview

Download
/*********** DO NOT ALTER ANYTHING BELOW THIS LINE ! ************/ var s_code=s.t();if(s_code)document.write(s_code)//-->